Alex C. Sapir
Board Member
Fulcrum Therapeutics, Inc. (FULC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alex C. Sapir
Alex C. Sapir is recorded as CEO and Board Member at Fulcrum Therapeutics, Inc. (FULC). Fulcrum Therapeutics, Inc. reported in an 8-K filed May 15, 2023 that Alex C. Sapir was appointed president and chief executive officer, effective July 1, 2023. Fulcrum Therapeutics, Inc. reported in an 8-K filed May 15, 2023 that Alex C. Sapir was appointed class II director, effective July 1, 2023. The proxy statement of Fulcrum Therapeutics, Inc. reports total compensation of $3,251,490 for Alex C. Sapir in fiscal 2025, including a base salary of $650,000. Disclosed compensation is on record for 3 fiscal years.
“On May 11, 2023, the Board also appointed Alex C. Sapir as Fulcrum's president and chief executive officer, and as a class II director, effective July 1, 2023.”
“On May 11, 2023, the Board also appointed Alex C. Sapir as Fulcrum's president and chief executive officer, and as a class II director, effective July 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-01–present
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fulcrum Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bryan Stuart CEO, COO, Board Member
- Robert J. Gould CEO
- Kate Haviland Chairman
- Mark Levin Chairman
- Alan A. Musso CFO
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
- Gregory Tourangeau Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer | $650,000 | $3,251,490 |
| 2024 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer | $650,000 | $1,003,300 |
| 2023 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer | $369,419 | $6,990,596 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.